Eli Lilly announced a $3 billion investment to expand its Pleasant Prairie, Wisconsin manufacturing plant, which it acquired earlier this year.
The expansion will increase production of its weight-loss drug Zepbound, diabetes treatments, and other medicines.
This investment, Lilly’s largest outside Indiana, aims to meet soaring demand for drugs like Zepbound and Mounjaro, which faced shortages earlier this year.
Lilly has committed over $23 billion to manufacturing expansions since 2020, CNBC has reported.
read more: [ Ссылка ]
Links for B.C.
Visit My Website
[ Ссылка ]
Follow Me On Facebook
[ Ссылка ]
Subscribe To My Patreon
[ Ссылка ]
Watch Me On YouTube
[ Ссылка ]
Follow Me On Twitter
[ Ссылка ]
Watch Me On Rumble
[ Ссылка ]
Follow Me On Gab
[ Ссылка ]
Follow Me On Truth Social
[ Ссылка ]
Follow Me On BlueSky
[ Ссылка ]
